The correlation between pretreatment serum hormone levels and treatment outcome for patients with prostatic cancer and bony metastasis-Reference-Cited by-同舟云学术

The correlation between pretreatment serum hormone levels and treatment outcome for patients with prostatic cancer and bony metastasis

Published:2002-05-01 Issue:7 Volume:89 Page:710-713
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Chen S.S.,Chen K.-K.,Lin A.T.L.,Chang Y.-H.,Wu H.H.,Chang L.S.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1464-410X.2002.02733.x/fullpdf

Reference28 articles.

1. Studies on prostatic cancer, the effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;Cancer Res,1941

2. Hormonal therapy of prostatic cancer;Scott;Cancer,1980

3. An exponential model relating censored survival data and concomitant information for prostatic cancer patients;Byar;J Cancer Inst,1974

4. Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate;Berry;Cancer,1979

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis;Current Opinion in Urology;2023-09-25

2. Circulating prolactin levels in newly diagnosed prostate cancer patients;Journal of Zankoy Sulaimani - Part A;2023-06-20

3. Serum prolactin level as a predictive factor for abiraterone response in patients with metastatic castration‐resistant prostate cancer;The Prostate;2022-06-23

4. Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL;International braz j urol;2019-01

5. Low Preoperative Prolactin Levels Predict Non-Organ Confined Prostate Cancer in Clinically Localized Disease;Urologia Internationalis;2019